306 related articles for article (PubMed ID: 18793417)
1. Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients.
Fu Q; Chen X; Cui H; Guo Y; Chen J; Shen N; Bao C
Arthritis Res Ther; 2008; 10(5):R112. PubMed ID: 18793417
[TBL] [Abstract][Full Text] [Related]
2. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
[TBL] [Abstract][Full Text] [Related]
3. Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.
Bauer JW; Petri M; Batliwalla FM; Koeuth T; Wilson J; Slattery C; Panoskaltsis-Mortari A; Gregersen PK; Behrens TW; Baechler EC
Arthritis Rheum; 2009 Oct; 60(10):3098-107. PubMed ID: 19790071
[TBL] [Abstract][Full Text] [Related]
4. Association of large intergenic noncoding RNA expression with disease activity and organ damage in systemic lupus erythematosus.
Wu Y; Zhang F; Ma J; Zhang X; Wu L; Qu B; Xia S; Chen S; Tang Y; Shen N
Arthritis Res Ther; 2015 May; 17(1):131. PubMed ID: 25994030
[TBL] [Abstract][Full Text] [Related]
5. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
7. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
[TBL] [Abstract][Full Text] [Related]
8. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H
Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160
[TBL] [Abstract][Full Text] [Related]
9. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Tam LS; Li EK; Lam CW
Ann Rheum Dis; 2006 Feb; 65(2):209-15. PubMed ID: 15975968
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of serum sCXCL16 in systemic lupus erythematosus; potential involvement in cutaneous and renal manifestations.
Qin M; Guo Y; Jiang L; Wang X
Clin Rheumatol; 2014 Nov; 33(11):1595-601. PubMed ID: 25015061
[TBL] [Abstract][Full Text] [Related]
11. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of chemokines and chemokine receptors with clinical features in newly diagnosed systemic lupus erythematosus].
Tao JH; Li XP; Li XM; Kan M; Zhai ZM; Wang W
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3051-4. PubMed ID: 17288835
[TBL] [Abstract][Full Text] [Related]
13. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus.
Bauer JW; Baechler EC; Petri M; Batliwalla FM; Crawford D; Ortmann WA; Espe KJ; Li W; Patel DD; Gregersen PK; Behrens TW
PLoS Med; 2006 Dec; 3(12):e491. PubMed ID: 17177599
[TBL] [Abstract][Full Text] [Related]
15. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
[TBL] [Abstract][Full Text] [Related]
16. Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus.
Vilá LM; Molina MJ; Mayor AM; Cruz JJ; Ríos-Olivares E; Ríos Z
Clin Rheumatol; 2007 May; 26(5):718-22. PubMed ID: 16924394
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus.
Enocsson H; Wetterö J; Eloranta ML; Gullstrand B; Svanberg C; Larsson M; Bengtsson AA; Rönnblom L; Sjöwall C
Front Immunol; 2021; 12():688753. PubMed ID: 34276678
[TBL] [Abstract][Full Text] [Related]
18. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus among male patients in Malaysia: how are we different from other geographical regions?
Shaharir SS; Kadir WDA; Nordin F; Bakar FA; Ting MWH; Jamil A; Mohd R; Wahab AA
Lupus; 2019 Jan; 28(1):137-144. PubMed ID: 30458692
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus.
Narumi S; Takeuchi T; Kobayashi Y; Konishi K
Cytokine; 2000 Oct; 12(10):1561-5. PubMed ID: 11023674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
